Pharmaceutical company Grünenthal invests €80m in Latin American production sites for enhanced global supply and quality.
Pharmaceutical company Grünenthal invests €80m in Latin American production sites to enhance its global network, ensuring reliable medicine supply for Latin America, Europe, and beyond. The investments include refurbishing a 3,500-square-meter solids plant in Chile and establishing a new plant in Ecuador. This standardizes product robustness, quality, and regulatory compliance across global manufacturing sites.
July 17, 2024
4 Articles